Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer.

Br J Cancer · 2021 · PMC8007618 · PMID 33473167

Europe PMC DOI

hedged sentence

0.0838

closest p · 1.7× alpha

0.0838

boldest claim

The sentences

showed a trendp = 0.0838so close (0.05 < p ≤ 0.1)

As expected, CGR HGSOC patients in the ALG5 -low subgroup showed a trend of better PFS compared to non-CGR patients (HH: HR = 0.543, 95% CI: 0.271–1.09, p = 0.0838; UVA-55: HR = 0.3, 95% CI: 0.0858–1.05, p = 0.0593).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.